Filing Details
- Accession Number:
- 0001753926-24-000573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-19 18:21:08
- Reporting Period:
- 2024-03-15
- Accepted Time:
- 2024-03-19 18:21:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347242 | Lipella Pharmaceuticals Inc. | LIPO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959250 | H Jonathan Kaufman | C/O Lipella Pharmaceuticals Inc. 7800 Susquehanna St., Suite 505 Pittsburgh PA 15208 | See Remarks Below. | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-18 | 30,000 | $0.79 | 863,849 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-03-19 | 25,000 | $0.87 | 888,849 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Acquisiton | 2024-03-15 | 80,000 | $0.00 | 80,000 | $0.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,000 | 2024-03-15 | 2034-03-15 | No | 4 | A | Direct |
Footnotes
- Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
- Reflects the weighted average price of the shares purchased on the open market in multiple transactions on March 18, 2024 at prices ranging from $0.77 to $0.80 per share, inclusive.
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
- Open market purchase by the reporting person of 25,000 shares of Common Stock.
- Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on March 19, 2024 at prices ranging from $0.75 to $0.89 per share, inclusive.
Billionaire Hedge Funds
